Figure 3 illustrates a compelling and clinically relevant pattern in serum AMH levels across three groups: healthy females, Turner syndrome (TS) patients without premature ovarian insufficiency (POI), and TS patients with POI. This evidence concerns the gene AMH and Turner syndrome.